RayzeBio, Inc.(RYZB)_个股概要_股票价格_最新资讯_行情走势_历史数据

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

RYZB RayzeBio, Inc.

停牌 05-28 17:18:22 EDT

62.49

+0.00

0.00%

最高62.49	最低62.49	成交量0.00
今开62.49	昨收62.49	日振幅0.00%
总市值37.44亿	流通市值21.76亿	总股本5,992万
成交额1,733万	换手率0.00%	流通股本3,482万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"RYZB","market":"US","secType":"STK","nameCN":"RayzeBio, Inc.","latestPrice":62.49,"timestamp":1708722000000,"preClose":62.49,"halted":3,"volume":0,"delay":0,"floatShares":34819731,"shares":59919502,"eps":-8.766259,"marketStatus":"停牌","marketStatusCode":4,"change":0,"latestTime":"05-28 17:18:22 EDT","open":62.49,"high":62.49,"low":62.49,"amount":17332645.682583,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-8.766259,"exchange":"NASDAQ","tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1716940800000},"adr":0,"listingDate":1694750400000,"adjPreClose":62.49,"volumeRatio":0},"requestUrl":"/m/hq/s/RYZB","defaultTab":"news","newsList":[{"id":"2408044186","title":"百时美施贵宝第四季度业绩好于预期","url":"https://stock-news.laohu8.com/highlight/detail?id=2408044186","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2408044186?lang=zh_cn&edition=full","pubTime":"2024-02-02 19:59","pubTimestamp":1706875153,"startTime":"0","endTime":"0","summary":" Michael Erman    路透2月2日 - 制药商百时美施贵宝  周五公布的第四季度业绩好于预期，原因是其贫血症新药Reblozyl和已退出专利的血癌药物Revlimid的销售业绩超过了华尔街的预测。该公司去年底宣布了一系列交易，以重新储备其产品线，并表示其第四季度收入为 114.8 亿美元。百时美施贵宝预计，随着癌症免疫疗法Opdivo和血液稀释剂Eliquis失去专利保护，这两种畅销药物在本十年晚些时候的销售额将有所下降。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2408061665","title":"未来一天的看点 - 2月2日星期五","url":"https://stock-news.laohu8.com/highlight/detail?id=2408061665","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2408061665?lang=zh_cn&edition=full","pubTime":"2024-02-02 03:45","pubTimestamp":1706816727,"startTime":"0","endTime":"0","summary":"根据 LSEG 的估计，受能源价格影响，全年净利润预计为 374 亿美元，低于 2022 年的 591 亿美元。预计 1 月份非农就业岗位将增加 180,000 个，12 月份为 216,000 个。1 月份的失业率可能从 12 月份的 3.7% 上升至 3.8%。同时，1 月份平均时薪预计将增长 0.3%，12 月份为增长 0.4%。工资同比增幅可能为 4.1%，与上月持平。另外，美国商务部人口普查局的数据预计将显示，12 月份工厂订单增长 0.2%，而 11 月份为增长 2.6%。医疗保险公司 Cigna Group 预计将公布第四季度财报。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2394734000","title":"“核药”赛道持续升温 美生物技术公司被溢价100%收购 上市还不到四个月","url":"https://stock-news.laohu8.com/highlight/detail?id=2394734000","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2394734000?lang=zh_cn&edition=full","pubTime":"2023-12-27 23:47","pubTimestamp":1703692021,"startTime":"0","endTime":"0","summary":"当地时间周二，跨国生物医药巨头百时美施贵宝宣布，其与生物技术公司RayzeBio， Inc．达成最终并购协议。协议显示，BMS将以每股62.50美元的价格收购RayzeBio，交易总价值约41亿美元。RayzeBio与“核药”据了解，本次让BMS溢价100%收购的RayzeBio是一家“放射性药物治疗”公司，专注于利用放射性同位素开发抗癌药物。仅上市不到四个月值得一提的是，RayzeBio是一家非常年轻的公司，成立于2020年。今年9月，RayzeBio以每股18美元的价格IPO上市，首日便收涨33%至每股24美元。","market":"hk","thumbnail":"http://imgcloud.jrjimg.cn/2023/12/cms_20231227234701868.jpg","type":0,"news_type":0,"thumbnails":["http://imgcloud.jrjimg.cn/2023/12/cms_20231227234701868.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://usstock.jrj.com.cn/2023/12/27234738902630.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2394242677","title":"美股异动 | 获施贵宝(BMY.US)41亿美元收购要约 RayzeBio(RYZB.US)","url":"https://stock-news.laohu8.com/highlight/detail?id=2394242677","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2394242677?lang=zh_cn&edition=full","pubTime":"2023-12-26 22:38","pubTimestamp":1703601500,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，周二，生物制药公司RayzeBio(RYZB.US)股价暴涨，截至发稿，该股涨超101%，报61.57美元。施贵宝(BMY.US)和RayzeBio宣布双方达成最终合并协议。根据协议条款，施贵宝将以每股62.50美元现金收购RayzeBio，总股本价值约41亿美元，以加强其抗癌药物业务。该交易预计将于2024年上半年完成。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1045505.html","is_publish_highlight":false,"gpt_icon":0},{"id":"1103912935","title":"盘前 | “妖股”频现！Rayzebio暴涨97%，亘喜生物涨59%；新能源汽车股上涨，理想涨超7%","url":"https://stock-news.laohu8.com/highlight/detail?id=1103912935","media":"老虎资讯综合","top":-1,"share":"https://www.laohu8.com/m/news/1103912935?lang=zh_cn&edition=full","pubTime":"2023-12-26 20:59","pubTimestamp":1703595557,"startTime":"0","endTime":"0","summary":"此次拟议收购将为阿斯利康的细胞疗法管线增添GC012F CAR-T细胞疗法。盘前行情$亘喜生物$盘前暴涨59%！Rayzebio盘前暴涨97%，据彭博，$施贵宝$将以每股62.50美元现金收购Rayzebio。新能源汽车股盘前普涨，$理想汽车$涨超7%，$蔚来$涨逾4%，$小鹏汽车$涨逾2%。","market":"us","thumbnail":"https://static.tigerbbs.com/ed4ee39e6b0f45214393093d70ba81a8","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/ed4ee39e6b0f45214393093d70ba81a8"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"gpt_icon":1},{"id":"2394249943","title":"百时美施贵宝将以约41亿美元收购RayzeBio","url":"https://stock-news.laohu8.com/highlight/detail?id=2394249943","media":"界面","top":-1,"share":"https://www.laohu8.com/m/news/2394249943?lang=zh_cn&edition=full","pubTime":"2023-12-26 20:58","pubTimestamp":1703595502,"startTime":"0","endTime":"0","summary":"百时美施贵宝（Bristol Myers Squibb）12月26日表示，将以约41亿美元收购RayzeBio，以加强其抗癌药物业务。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202312262058227904027b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202312262058227904027b&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"1140088663","title":"美股异动 | Rayzebio盘前暴涨98%，获百时美施贵宝溢价104%收购要约","url":"https://stock-news.laohu8.com/highlight/detail?id=1140088663","media":"老虎资讯综合","top":-1,"share":"https://www.laohu8.com/m/news/1140088663?lang=zh_cn&edition=full","pubTime":"2023-12-26 20:31","pubTimestamp":1703593893,"startTime":"0","endTime":"0","summary":"12月26日，Rayzebio盘前暴涨98%，据彭博，$施贵宝(BMY)$将以每股62.50美元现金收购Rayzebio。","market":"us","thumbnail":"https://static.tigerbbs.com/a3f00ceb9616da9533f38a065954d799","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/a3f00ceb9616da9533f38a065954d799"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"gpt_icon":0},{"id":"2394245154","title":"更新版 1-百时美施贵宝将以约 41 亿美元收购 RayzeBio","url":"https://stock-news.laohu8.com/highlight/detail?id=2394245154","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2394245154?lang=zh_cn&edition=full","pubTime":"2023-12-26 20:09","pubTimestamp":1703592545,"startTime":"0","endTime":"0","summary":"(在第 2、3 段增加了详细信息)    路透12月26日 - 百时美施贵宝  周二表示，将以约41亿美元的价格收购放射性药物公司RayzeBio  。布里斯托尔公司表示，它将为每股RayzeBio股票支付62.50美元现金，比股票最后收盘价溢价104%。 交易宣布前，RayzeBio 股票停牌。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://rayzebio.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":1.7276},{"period":"1year","weight":2.4717},{"period":"ytd","weight":0.0051}],"compareEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0.0475},{"period":"3month","weight":0.0425},{"period":"6month","weight":0.1628},{"period":"1year","weight":0.2768},{"period":"ytd","weight":0.1139}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"RayzeBio, Inc.于2020年1月2日在特拉华州成立，总部设在加利福尼亚州圣地亚哥。该公司正在建立一家垂直整合的放射性药物治疗公司。该公司在3期临床试验中领导项目。该公司在具有重大市场机会的治疗领域创建了多种候选药物的管道。该公司最初的重点是建立一个市场领先的生长抑素受体2型，或SSTR2，专营权。随着针对SSTR2的多种诊断和治疗商业产品的出现，它是一种在多种实体瘤中表达的经临床验证的靶点。该公司的主要候选药物RYZ101被设计用于向过度表达SSTR2的肿瘤递送一种高效的α粒子放射性同位素Actinium 225或Ac225。RYZ101由与Ac225结合的多肽结合剂DOTATATE和螯合剂组成。美国食品和药物管理局（FDA）已批准将DOTATATE用作SSTR2诊断成像和治疗剂的多肽结合剂。","exchange":"NASDAQ","name":"RayzeBio, Inc.","nameEN":"RayzeBio, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"RayzeBio, Inc.(RYZB)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供RayzeBio, Inc.(RYZB)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"RayzeBio, Inc.,RYZB,RayzeBio, Inc.股票,RayzeBio, Inc.股票老虎,RayzeBio, Inc.股票老虎国际,RayzeBio, Inc.行情,RayzeBio, Inc.股票行情,RayzeBio, Inc.股价,RayzeBio, Inc.股市,RayzeBio, Inc.股票价格,RayzeBio, Inc.股票交易,RayzeBio, Inc.股票购买,RayzeBio, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"RayzeBio, Inc.(RYZB)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供RayzeBio, Inc.(RYZB)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}

公司概况